Boryung Hemosis VL Solution (Sodium Bicarbonate)
Sodium Bicarbonate 8.4g
Prescription medication
Boryung Co., Ltd.
MFDS item code 201801385 · Notified 2018.03.28
Effect on preparation of dialysis solution for acute and chronic renal failure and detoxification.
This medication is used for preparing dialysis solutions for patients with acute and chronic renal failure, and it is also used for dialysis in cases of detoxification from toxic substances. Therefore, it is used to assist in dialysis treatment for patients with decreased kidney function or those exposed to toxic substances.
When using the defined acetate-containing dialysis solution (Solution A), this preparation can create a sodium bicarbonate-based dialysis solution containing HCO3- at 35 mEq/L. It is used as dialysis fluid in hemodialysis when using a dilution ratio of 1:1.225:32.775 of acetate-containing dialysis solution (Solution A), this preparation, and purified water.
This medication should not be used in patients with low blood pressure and rapid heart rate. It should also be avoided in patients with pulmonary edema or severe changes in electrocardiogram. Patients with high serum potassium levels and those with blood clotting issues should not be administered this medication. Caution should be exercised when using this medication in patients with severe liver impairment or those who have metabolic issues due to diabetes. Patients taking digitalis preparations should be careful as this medication may decrease serum potassium levels, increasing the risk of drug toxicity. Patients with high serum calcium and phosphorus levels before dialysis should also use this medication with caution. Inadequate calorie intake or diet restrictions due to diabetes may lead to hypoglycemia, thus requiring attention. When using this medication, hypoglycemic symptoms may occur, so appropriate measures such as glucose injection or sugar supply should be taken if symptoms arise. Since serum calcium levels may increase, dialysis solutions should be adjusted if hypercalcemia is suspected. Osteoporosis or osteomalacia-related complications may occur, so appropriate treatment such as vitamin D3 supplementation is necessary. Abnormal calcium deposition may happen, so maintaining serum phosphorus levels within the normal range is crucial. During dialysis, symptoms such as headache, nausea, vomiting, convulsions, and altered consciousness may present, hence dialysis intensity should be adjusted in these cases. It can influence the circulatory system, potentially causing symptoms of hypotension or shock, which necessitates stopping or adjusting dialysis and receiving appropriate treatment if symptoms appear. This medication is used in dialysis for patients with chronic renal failure and is suitable when it is difficult to improve metabolic acidosis, or when hypotension or dialysis disequilibrium syndrome occurs. It is also used for patients who find it difficult to control hyperglycemia due to glucose metabolism abnormalities. During use, it is advisable to regularly check electrolytes, acid-base balance, and blood sugar via blood tests. Pregnant women or those who may become pregnant should only use this medication if the therapeutic benefits outweigh the risks, as its safety has not been established. Safety in children has not been sufficiently confirmed, so caution is necessary. Elderly patients are at risk of bone complications when using this medication; therefore, regular check-ups and management such as vitamin D3 supplementation are required. Dialysis diluent water should be clean water that has undergone appropriate purification processes, and care should be taken regarding dialysis membrane damage and bleeding tendencies. When preparing, do not directly mix this medication with the electrolyte solution for artificial renal dialysis, and it should be accurately prepared with the specified diluent. If the dilution concentration is too high or low, side effects such as headache, abnormal blood pressure, and altered consciousness may occur, necessitating care. It is essential to confirm the electrolyte concentration and pH of the dialysis solution before use. This medication should not be used for injections or peritoneal dialysis, and the prepared dialysis solution should be used immediately. It is safe to use the dialysis solution adjusted to body temperature.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent exposure to air and moisture, ideally at room temperature between 1 to 30 degrees Celsius. Storing it this way helps to preserve the efficacy of the medication for a longer duration and prevents degradation.
A colorless, transparent liquid filled in a plastic container
6.3L per container
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sodium Bicarbonate 8.4g
Prescription medication
Boryung Co., Ltd.
Sodium Bicarbonate 84mg
Injections · Prescription medication
Dae Won Pharmaceutical Co., Ltd.
Sodium Bicarbonate 84mg
Injections · Prescription medication
Jeil Pharmaceutical Co., Ltd.
Sodium Bicarbonate 7g
Solution · Prescription medication
JW Pharmaceutical Corp.
Sodium Bicarbonate 1g
Prescription medication
Vantiv Korea Co., Ltd.
Sodium Bicarbonate 5.83g
Solution · Prescription medication
JW Pharmaceutical Corp.
Sodium Bicarbonate 1g
Prescription medication
Fresenius Medical Care Korea Co., Ltd.
Sodium Bicarbonate 84mg
Injections · Prescription medication
Daehan Pharmaceutical Industry Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.